The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda

Christina I. Nieves, Angela Kaida, George R. Seage, Jerome Kabakyenga, Winnie Muyindike, Yap Boum, A. Rain Mocello, Jeffrey N. Martin, Peter W. Hunt, Jessica E. Haberer, David Bangsberg, Lynn T. Matthews

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective The objective was to determine individual and dyadic factors associated with effective contraceptive use among human immunodeficiency virus (HIV)-infected women accessing antiretroviral therapy (ART) in rural Uganda. Study design HIV-infected women enrolled in the Uganda AIDS Rural Treatment Outcomes cohort completed questionnaires (detailing sociobehavioral characteristics, sexual and reproductive history, contraceptive use, fertility desires) and phlebotomy (October 2011-March 2013). We describe prevalence of effective contraceptive use (i.e., consistent condom use and/or oral contraceptives, injectable hormonal contraception, intrauterine device, female sterilization) in the previous 6 months among sexually active, nonpregnant women (18-40 years). We assessed covariates of contraceptive use using multivariable logistic regression. Results A total of 362 women (median values: age 30 years, CD4 count 397 cells/mm3, 4.0 years since ART initiation) were included. Among 284 sexually active women, 50% did not desire a(nother) child, and 51% had a seroconcordant partner. Forty-five percent (n= 127) reported effective contraceptive use, of whom 57% (n= 72) used condoms, 42% (n= 53) injectables, 12% (n= 15) oral contraceptives and 11% (n= 14) other effective methods. Dual contraception was reported by 6% (n= 8). Only "partnership fertility desire" was independently associated with contraceptive use; women who reported that neither partner desired a child had significantly increased odds of contraceptive use (adjusted odds ratio: 2.40, 95% confidence interval: 1.07-5.35) compared with women in partnerships where at least one partner desired a child. Conclusions Less than half of sexually active HIV-infected women accessing ART used effective contraception, of which 44% (n= 56) relied exclusively on male condoms, highlighting a continued need to expand access to a wider range of longer-acting female-controlled contraceptive methods. Association with partnership fertility desire underscores the need to include men in reproductive health programming. Implications statement Less than half of sexually active HIV-infected women accessing ART in rural Uganda reported using effective contraception, of whom 44% relied exclusively on the male condom. These findings highlight the need to expand access to a wider range of longer-acting, female-controlled contraceptive methods for women seeking to limit or space pregnancies. Use of contraception was more likely when both the male and female partner expressed concordant desires to limit future fertility, emphasizing the importance of engaging men in reproductive health programming.

Original languageEnglish (US)
Pages (from-to)152-159
Number of pages8
JournalContraception
Volume92
Issue number2
DOIs
StatePublished - Aug 1 2015
Externally publishedYes

Fingerprint

Uganda
Contraceptive Agents
HIV
Contraception
Condoms
Fertility
Female Contraceptive Agents
Therapeutics
Reproductive Health
Contraceptives, Oral, Hormonal
Reproductive Sterilization
Reproductive History
Intrauterine Devices
Injections
Phlebotomy
CD4 Lymphocyte Count
Oral Contraceptives
Acquired Immunodeficiency Syndrome
Logistic Models
Odds Ratio

Keywords

  • Antiretroviral therapy
  • Contraceptive use
  • Family planning
  • HIV
  • Uganda

ASJC Scopus subject areas

  • Medicine(all)
  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Nieves, C. I., Kaida, A., Seage, G. R., Kabakyenga, J., Muyindike, W., Boum, Y., ... Matthews, L. T. (2015). The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. Contraception, 92(2), 152-159. https://doi.org/10.1016/j.contraception.2015.04.011

The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. / Nieves, Christina I.; Kaida, Angela; Seage, George R.; Kabakyenga, Jerome; Muyindike, Winnie; Boum, Yap; Mocello, A. Rain; Martin, Jeffrey N.; Hunt, Peter W.; Haberer, Jessica E.; Bangsberg, David; Matthews, Lynn T.

In: Contraception, Vol. 92, No. 2, 01.08.2015, p. 152-159.

Research output: Contribution to journalArticle

Nieves, CI, Kaida, A, Seage, GR, Kabakyenga, J, Muyindike, W, Boum, Y, Mocello, AR, Martin, JN, Hunt, PW, Haberer, JE, Bangsberg, D & Matthews, LT 2015, 'The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda', Contraception, vol. 92, no. 2, pp. 152-159. https://doi.org/10.1016/j.contraception.2015.04.011
Nieves, Christina I. ; Kaida, Angela ; Seage, George R. ; Kabakyenga, Jerome ; Muyindike, Winnie ; Boum, Yap ; Mocello, A. Rain ; Martin, Jeffrey N. ; Hunt, Peter W. ; Haberer, Jessica E. ; Bangsberg, David ; Matthews, Lynn T. / The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. In: Contraception. 2015 ; Vol. 92, No. 2. pp. 152-159.
@article{1abc12b8b9d649a183020eed9c3763e3,
title = "The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda",
abstract = "Objective The objective was to determine individual and dyadic factors associated with effective contraceptive use among human immunodeficiency virus (HIV)-infected women accessing antiretroviral therapy (ART) in rural Uganda. Study design HIV-infected women enrolled in the Uganda AIDS Rural Treatment Outcomes cohort completed questionnaires (detailing sociobehavioral characteristics, sexual and reproductive history, contraceptive use, fertility desires) and phlebotomy (October 2011-March 2013). We describe prevalence of effective contraceptive use (i.e., consistent condom use and/or oral contraceptives, injectable hormonal contraception, intrauterine device, female sterilization) in the previous 6 months among sexually active, nonpregnant women (18-40 years). We assessed covariates of contraceptive use using multivariable logistic regression. Results A total of 362 women (median values: age 30 years, CD4 count 397 cells/mm3, 4.0 years since ART initiation) were included. Among 284 sexually active women, 50{\%} did not desire a(nother) child, and 51{\%} had a seroconcordant partner. Forty-five percent (n= 127) reported effective contraceptive use, of whom 57{\%} (n= 72) used condoms, 42{\%} (n= 53) injectables, 12{\%} (n= 15) oral contraceptives and 11{\%} (n= 14) other effective methods. Dual contraception was reported by 6{\%} (n= 8). Only {"}partnership fertility desire{"} was independently associated with contraceptive use; women who reported that neither partner desired a child had significantly increased odds of contraceptive use (adjusted odds ratio: 2.40, 95{\%} confidence interval: 1.07-5.35) compared with women in partnerships where at least one partner desired a child. Conclusions Less than half of sexually active HIV-infected women accessing ART used effective contraception, of which 44{\%} (n= 56) relied exclusively on male condoms, highlighting a continued need to expand access to a wider range of longer-acting female-controlled contraceptive methods. Association with partnership fertility desire underscores the need to include men in reproductive health programming. Implications statement Less than half of sexually active HIV-infected women accessing ART in rural Uganda reported using effective contraception, of whom 44{\%} relied exclusively on the male condom. These findings highlight the need to expand access to a wider range of longer-acting, female-controlled contraceptive methods for women seeking to limit or space pregnancies. Use of contraception was more likely when both the male and female partner expressed concordant desires to limit future fertility, emphasizing the importance of engaging men in reproductive health programming.",
keywords = "Antiretroviral therapy, Contraceptive use, Family planning, HIV, Uganda",
author = "Nieves, {Christina I.} and Angela Kaida and Seage, {George R.} and Jerome Kabakyenga and Winnie Muyindike and Yap Boum and Mocello, {A. Rain} and Martin, {Jeffrey N.} and Hunt, {Peter W.} and Haberer, {Jessica E.} and David Bangsberg and Matthews, {Lynn T.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.contraception.2015.04.011",
language = "English (US)",
volume = "92",
pages = "152--159",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda

AU - Nieves, Christina I.

AU - Kaida, Angela

AU - Seage, George R.

AU - Kabakyenga, Jerome

AU - Muyindike, Winnie

AU - Boum, Yap

AU - Mocello, A. Rain

AU - Martin, Jeffrey N.

AU - Hunt, Peter W.

AU - Haberer, Jessica E.

AU - Bangsberg, David

AU - Matthews, Lynn T.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Objective The objective was to determine individual and dyadic factors associated with effective contraceptive use among human immunodeficiency virus (HIV)-infected women accessing antiretroviral therapy (ART) in rural Uganda. Study design HIV-infected women enrolled in the Uganda AIDS Rural Treatment Outcomes cohort completed questionnaires (detailing sociobehavioral characteristics, sexual and reproductive history, contraceptive use, fertility desires) and phlebotomy (October 2011-March 2013). We describe prevalence of effective contraceptive use (i.e., consistent condom use and/or oral contraceptives, injectable hormonal contraception, intrauterine device, female sterilization) in the previous 6 months among sexually active, nonpregnant women (18-40 years). We assessed covariates of contraceptive use using multivariable logistic regression. Results A total of 362 women (median values: age 30 years, CD4 count 397 cells/mm3, 4.0 years since ART initiation) were included. Among 284 sexually active women, 50% did not desire a(nother) child, and 51% had a seroconcordant partner. Forty-five percent (n= 127) reported effective contraceptive use, of whom 57% (n= 72) used condoms, 42% (n= 53) injectables, 12% (n= 15) oral contraceptives and 11% (n= 14) other effective methods. Dual contraception was reported by 6% (n= 8). Only "partnership fertility desire" was independently associated with contraceptive use; women who reported that neither partner desired a child had significantly increased odds of contraceptive use (adjusted odds ratio: 2.40, 95% confidence interval: 1.07-5.35) compared with women in partnerships where at least one partner desired a child. Conclusions Less than half of sexually active HIV-infected women accessing ART used effective contraception, of which 44% (n= 56) relied exclusively on male condoms, highlighting a continued need to expand access to a wider range of longer-acting female-controlled contraceptive methods. Association with partnership fertility desire underscores the need to include men in reproductive health programming. Implications statement Less than half of sexually active HIV-infected women accessing ART in rural Uganda reported using effective contraception, of whom 44% relied exclusively on the male condom. These findings highlight the need to expand access to a wider range of longer-acting, female-controlled contraceptive methods for women seeking to limit or space pregnancies. Use of contraception was more likely when both the male and female partner expressed concordant desires to limit future fertility, emphasizing the importance of engaging men in reproductive health programming.

AB - Objective The objective was to determine individual and dyadic factors associated with effective contraceptive use among human immunodeficiency virus (HIV)-infected women accessing antiretroviral therapy (ART) in rural Uganda. Study design HIV-infected women enrolled in the Uganda AIDS Rural Treatment Outcomes cohort completed questionnaires (detailing sociobehavioral characteristics, sexual and reproductive history, contraceptive use, fertility desires) and phlebotomy (October 2011-March 2013). We describe prevalence of effective contraceptive use (i.e., consistent condom use and/or oral contraceptives, injectable hormonal contraception, intrauterine device, female sterilization) in the previous 6 months among sexually active, nonpregnant women (18-40 years). We assessed covariates of contraceptive use using multivariable logistic regression. Results A total of 362 women (median values: age 30 years, CD4 count 397 cells/mm3, 4.0 years since ART initiation) were included. Among 284 sexually active women, 50% did not desire a(nother) child, and 51% had a seroconcordant partner. Forty-five percent (n= 127) reported effective contraceptive use, of whom 57% (n= 72) used condoms, 42% (n= 53) injectables, 12% (n= 15) oral contraceptives and 11% (n= 14) other effective methods. Dual contraception was reported by 6% (n= 8). Only "partnership fertility desire" was independently associated with contraceptive use; women who reported that neither partner desired a child had significantly increased odds of contraceptive use (adjusted odds ratio: 2.40, 95% confidence interval: 1.07-5.35) compared with women in partnerships where at least one partner desired a child. Conclusions Less than half of sexually active HIV-infected women accessing ART used effective contraception, of which 44% (n= 56) relied exclusively on male condoms, highlighting a continued need to expand access to a wider range of longer-acting female-controlled contraceptive methods. Association with partnership fertility desire underscores the need to include men in reproductive health programming. Implications statement Less than half of sexually active HIV-infected women accessing ART in rural Uganda reported using effective contraception, of whom 44% relied exclusively on the male condom. These findings highlight the need to expand access to a wider range of longer-acting, female-controlled contraceptive methods for women seeking to limit or space pregnancies. Use of contraception was more likely when both the male and female partner expressed concordant desires to limit future fertility, emphasizing the importance of engaging men in reproductive health programming.

KW - Antiretroviral therapy

KW - Contraceptive use

KW - Family planning

KW - HIV

KW - Uganda

UR - http://www.scopus.com/inward/record.url?scp=84937525850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937525850&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2015.04.011

DO - 10.1016/j.contraception.2015.04.011

M3 - Article

C2 - 25983013

AN - SCOPUS:84937525850

VL - 92

SP - 152

EP - 159

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 2

ER -